Chemistry Professor Contributes to a Cancer Treatment Now in Clinical Trials

Max Royzen, an associate professor of Chemistry, partnered with San Francisco-based biotech firm Shasqi to develop an anticancer therapy that utilizes bio-orthogonal click chemistry to target a powerful drug at cancerous tumors.Bio-orthogonal click chemistry is a process by which two highly reactive compounds, selective for each other, react inside a live organism. According to Royzen, this makes the process incredibly valuable in medical chemistry, and in particular cancer treatment, because it can target the cancerous cells while sparing healthy cells.

Read the article: Chemistry Professor Contributes to a Cancer Treatment Now in Clinical Trials